Among the long-acting injectable (LAI) antipsychotics, aripiprazole lauroxil — sold as Aristada — has carved out a particular niche by offering more dosing flexibility than almost any other product on the US market. It comes in four strengths, three injection intervals, and pairs with a one-day starter (Aristada Initio) that lets prescribers skip the usual three weeks of oral overlap. For people who hate pills or who find adherence to daily oral medication impossible, that flexibility can be the difference between staying out of hospital and not.
Aristada is a long-acting injectable form of aripiprazole approved for schizophrenia, with monthly, six-week, and eight-week dosing options and an initiation regimen that can replace the standard 21 days of oral overlap.
What Aristada is
Aristada is the brand name for aripiprazole lauroxil, a prodrug of aripiprazole. After injection into a muscle, enzymes in the body slowly cleave the lauroxil portion, releasing aripiprazole into the bloodstream over weeks. Because the release is so gradual, blood levels stay relatively steady between doses — which is the entire point of switching from a daily pill to an injection.
It is a different product from Abilify Maintena (aripiprazole monohydrate), although both deliver the same active drug. The two have different release profiles, dosing strategies, and initiation requirements.
Who it's for
Aristada is FDA-approved for the treatment of schizophrenia in adults. Like all LAIs, it is most useful for people who:
- Have a history of relapse linked to missed oral doses
- Have anosognosia and decline daily medication consistently
- Prefer not to think about pills every day
- Have responded well to oral aripiprazole and want to consolidate their regimen
Before starting Aristada, the patient should generally have tolerated oral aripiprazole for long enough to confirm the drug is a reasonable fit and that no acute hypersensitivity exists.
The four dosing strengths and three intervals
According to FDA labelling, Aristada is supplied in four strengths that map to specific intervals:
- 441 mg — every 4 weeks (monthly)
- 662 mg — every 4 weeks
- 882 mg — every 4 weeks or every 6 weeks
- 1064 mg — every 8 weeks
The 8-week option (1064 mg) is unusual in the LAI world; most other LAIs require monthly or every-3-month dosing. For people who travel, work irregular schedules, or struggle to make appointments, two-month dosing changes the lived experience considerably.
The initiation problem — and Aristada Initio
Most LAIs build to therapeutic levels slowly. With Aristada specifically, after the first injection it takes around three weeks for blood levels to approach steady state. The traditional answer was to overlap with oral aripiprazole for 21 days after the first injection — a workable plan for many patients but a logistical headache for those who came to LAIs in the first place because they could not reliably take pills.
Aristada Initio is a separate one-time intramuscular injection (675 mg) plus a single 30 mg oral aripiprazole dose, designed to replace those 21 days of oral overlap. The Initio formulation uses smaller drug particles that dissolve faster, giving patients useful aripiprazole levels within days. After receiving Aristada Initio plus the first Aristada maintenance injection, no further oral overlap is required.
This single change has meaningfully expanded the population of people who can realistically be started on Aristada in real-world settings — including in inpatient units where discharge needs to happen quickly.
Switching from oral aripiprazole
For someone already stable on oral aripiprazole, the conversion is more straightforward. Many prescribers continue oral aripiprazole for around 21 days after the first Aristada injection, then taper. Others use Aristada Initio to shorten the overlap. The choice usually depends on patient preference, prior adherence, and the inpatient or outpatient setting.
Where it's injected
Aristada is given as a deep intramuscular (IM) injection in either the deltoid muscle (smaller doses) or the gluteal muscle (larger doses, including 882 mg, 1064 mg, and the Initio dose). It must be administered by a healthcare professional. Injection technique matters — see our guide to injection-site care for what to expect and how to manage soreness.
Common side effects
Aristada's side effect profile mirrors oral aripiprazole closely:
- Akathisia — restlessness, an inner urge to move; one of the most common reasons people discontinue. See our akathisia management guide.
- Injection-site reactions — pain, swelling, and induration at the injection site, especially with larger volumes
- Headache and mild insomnia
- Weight gain — modest compared with olanzapine or clozapine, but possible
- Tremor and other extrapyramidal symptoms
You develop a high fever with muscle rigidity (possible neuroleptic malignant syndrome), uncontrollable involuntary movements (possible tardive dyskinesia), severe akathisia that becomes intolerable, or signs of an allergic reaction.
How effective is it?
Pivotal trials submitted to the FDA showed that aripiprazole lauroxil significantly reduced symptoms in schizophrenia compared with placebo over 12 weeks, and naturalistic studies suggest substantially lower relapse rates than oral aripiprazole alone over a year — consistent with the broader LAI literature reviewed in network meta-analyses (Schneider-Thoma et al., Lancet 2022). LAIs as a class reduce hospitalisation more than the same drug given orally, particularly in people with previous adherence problems.
Cost and access
Aristada is a brand-name product and considerably more expensive than oral aripiprazole. Most US insurers cover it under medical (not pharmacy) benefits because it is administered by a clinician. Patient assistance is available through the manufacturer, and many community mental health centres can navigate prior authorisation on behalf of patients. The cost calculation often shifts when you include avoided hospitalisations.
Practical questions to ask your prescriber
- Which interval — 4, 6, or 8 weeks — are we aiming for, and why?
- Will we use Aristada Initio or 21 days of oral overlap to start?
- What's our plan for missed appointments?
- How will we monitor for side effects, especially akathisia?
- If Aristada doesn't work for me, what's the next step?
This article is for educational purposes only and is not medical advice. Information is summarised from publicly available FDA labelling and peer-reviewed sources. Always consult your prescribing clinician before starting, stopping, or changing any medication.